Latest news with #SantaAna
CBS News
a day ago
- CBS News
Getaway driver runs over security guard after robbery in Santa Ana parking lot
A security guard was seriously injured after a robbery suspect ran him over in a Santa Ana parking lot. The Santa Ana Police Department said the robbery happened outside of the Food 4 Less on Bristol Street. Investigators said a young woman stole two gold chains from an elderly man before jumping into a white Mercedes-Benz SUV. Surveillance footage shows the security guard trying to stop the car in the parking lot. However, the getaway driver did not stop and ran over his leg. Officers said he had to have a few of his toes amputated. The elderly man who was robbed said he believed the woman who stole his jewelry was around 20 years old. He added that he was loading heavy cases of water into his car when the suspect approached him and attempted to help. The victim offered the woman a few dollars, but she refused. Instead, she put a bracelet on his wrist and something else around his neck. Santa Ana police said suspects commonly use this technique to distract victims and unclasp jewelry. The victim stated that he was able to save his gold cross before the woman escaped.
Yahoo
3 days ago
- Business
- Yahoo
NKGen Biotech Announces New Funding to Regain Compliance with Reporting Obligations and Listing Standards
Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants. New funding provides for necessary resources to regain compliance with reporting obligations and listing standards. Share trading will move to the OTC Expert Market temporarily, with potential to uplist to OTCQB as soon as SEC filings are current, with plan to return to Nasdaq or to NYSE American. SANTA ANA, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) ('NKGen' or the 'Company'), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer ('NK') cell therapeutics, today announced that it has raised $2 million in new capital from a Japanese strategic investor, who will help NKGen bring its novel NK cell therapy, troculeucel, autologous expanded NK cell therapy, to the Japanese market. The new investment was made in the form of shares of the Company's common stock priced at $0.25 per share and warrants, as described in the Company's Form 8-K filed with the Securities and Exchange Commission on July 16, 2025. This new injection of capital, the Company's ramping up of its Phase 2 clinical trial, the expected near-term satisfaction of public company reporting requirements and satisfaction of the previously disclosed payment obligation on the Company's senior secured debt are all critical to position the Company for long-term success. 'This past year presented significant external challenges, particularly stemming from the unexpected bankruptcy of our former parent company, NKMax Co., Ltd. in June 2024,' said Paul Y. Song, M.D., Chairman and Chief Executive Officer of NKGen. 'This event initially disrupted our ability to raise capital in the U.S. despite the encouraging progress we continued to make in our clinical trials and compassionate use cases. However, our team remained focused and committed to our mission. Through disciplined execution of our science and clinical programs, we not only sustained our momentum but also succeeded in securing the capital necessary to acquire a majority stake in NKMax out of bankruptcy, as previously disclosed. This transaction, expected to officially close in the coming month, removes a major overhang and allows us to consolidate key intellectual property rights across Asia. This strategic acquisition has already sparked renewed interest from both U.S. and international investors. We look forward to sharing further details in the near future about NKMax and strategic relationships and plans in Asia.' 'This marks our first strategic investor in an important market for our therapy for Alzheimer's and other neurodegenerative diseases,' said James Graf, NKGen's Interim Chief Financial Officer. 'As in our other recently announcing funding, this new funding comes at a pivotal time for the Company, which has faced operational challenges due to limited financial resources and the need to make hard decisions on our use of cash, including the unfortunate but unavoidable delay in our financial filings. With all the necessary service providers fully engaged on the effort now, we're on track to regain compliance in the near term.' Mr. Graf continued, 'The Company has been informed by the OTC Markets Group that its trading will move from OTC Pink to the Expert Market until it regains compliance in its financial filings. The Expert Market allows for limited trading but does not allow public access to bid and ask prices or other information, including trading volume. Instead, pricing information will only be accessible to brokers and market makers. The move will make it more difficult for investors to freely trade the shares of NKGen during this short period until we regain filing compliance. We take our filing obligations seriously and greatly regret the short-term impact resulting from our prior limited access to capital. We ask our investors for patience during this time, after which we expect to emerge on OTCQB and later back on Nasdaq well-positioned for the future.' The Company also announced that it is committed to uplisting back to Nasdaq or to NYSE American as soon as it meets the requirements for newly listed companies, including among other things SEC filing compliance, minimum market capitalization and public float and minimum share price. On February 25, 2025, the Company's shareholders approved a reverse split that is intended to aid in compliance with the share price requirement before uplisting, if so exercised. About Troculeucel Troculeucel is a novel cell-based, patient specific, ex vivo expanded autologous NK cell immunotherapeutic drug candidate. NKGen is developing troculeucel for the treatment of neurodegenerative disorders and a broad range of cancers. Troculeucel is the International Nonproprietary Name ('INN') for SNK01 assigned by the World Health Organization ('WHO'). The WHO INN approval of troculeucel establishes a universally recognized nonproprietary drug name for SNK01 and marks a significant step on NKGen's journey toward bringing this therapy to market. About NKGen Biotech NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic NK cell therapeutics. NKGen is headquartered in Santa Ana, California, USA. For more information, please visit Forward-Looking Statements Statements contained in this press release may contain 'forward-looking statements' within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may be identified by the use of words such as 'anticipate', 'believe', 'could', 'continue', 'expect', 'estimate', 'may', 'plan', 'outlook', 'future' and 'project' and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Because such statements are subject to risks and uncertainties, many of which are outside of the Company's control, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding the Company's plans and expected timing for developing troculeucel and SNK02, including the expected timing of completing and announcing further results from its ongoing clinical studies; and the Company's expected timing for developing its product candidates and potential benefits of its product candidates. Risks that contribute to the uncertain nature of the forward-looking statements include: the Company's ability to execute its plans and strategies; risks related to performing clinical studies; the risk that initial and interim results of a clinical study do not necessarily predict final results and that one or more of the clinical outcomes may materially change as patient enrollment continues, following more comprehensive reviews of the data, and as more patient data become available; potential delays in the commencement, enrollment and completion of clinical studies and the reporting of data therefrom; the risk that studies will not be completed as planned; the risk that the abstract will not be published as planned including delays in timing, format, or accessibility; and NKGen's ability to raise additional funding to complete the development of its product candidates. These and other risks and uncertainties are described more fully under the caption 'Risk Factors' and elsewhere in the Company's filings and reports, which may be accessed for free by visiting the Securities and Exchange Commission's website at and on the Company's website under the subheading 'Investors—Financial and Filings'. Investors should take such risks into account and should not rely on forward-looking statements when making investment decisions. All forward-looking statements contained in this press release speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law. Internal Contact: Denise Chua, MBA, CLS, MLS (ASCP)SVP, Corporate Affairs949-396-6830dchua@ External Contact: Kevin GardnerManaging DirectorLifeSci Advisors, LLCkgardner@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 days ago
- Yahoo
Father of 3 Marine Brothers Released from Immigration Detention Center Nearly a Month After Detainment
Narciso Barranco was detained by border patrol agents while doing landscaping work outside an IHOP in Santa Ana, Calif., on June 21 He was released on Tuesday, July 15, from California's Adelanto Detention Center on a $3,000 bond Video footage obtained by CBS News captured the emotional moment he was reunited with one of his sonsNearly a month after being detained by ICE, Narciso Barranco, a father of three U.S. Marines, has been released from an immigration detention center. According to NBC Los Angeles, Barranco, 48, was released on Tuesday, July 15, from California's Adelanto Detention Center on a $3,000 bond. He is scheduled to appear in court again in August. Orange City councilmember Arianna Barrios said on Facebook that the hearing is to "adjust his status to parole in place based on the fact that his wife is a US citizen and his three American-born sons are active duty US military." Video footage of the moment he was released from federal custody was obtained by CBS News, showing Barranco accompanied by a female guard as he walked out of the center wearing a brown jacket and a brown hat, while carrying a plastic bag. Moments after, he hugs one of his three sons and another man who is with them, according to the video's caption. "The father of three U.S. service members is now seeking privacy and medical care as his legal case continues with a hearing set for August," the caption reads. Barranco's 25-year-old Marine Corps veteran son, Alejandro, told NBC Los Angeles that when his father stepped out of the detention center, "he was wearing the same clothes, and he was crying." Lisa Ramirez, Barranco's immigration attorney, told The Orange County Register that after he was released to his family around 2 p.m., he was taken to the hospital for a physical check-up. She said that while "Narciso is very happy to be reunited with his family," he "clearly will need time to decompress and get reacclimated." "He is, with good reason, traumatized by this whole experience and will need time to heal both physically and emotionally," Ramirez said. Barranco's release comes after he was approached on Saturday, June 21, by masked men who were wearing vests that read 'US Border Patrol Police' while doing landscaping work outside an IHOP in Santa Ana, Calif. Video footage obtained by CNN and ABC affiliate KABC shows the masked men pinning Barranco down on the street and punching him before taking him into custody. When previously reached out for comment by PEOPLE, DHS Assistant Secretary for Public Affairs Tricia McLaughlin said in a statement that an 'illegal alien' was arrested by Border Patrol agents after trying to 'evade law enforcement.' McLaughlin claimed Barranco "turned and swung a weed whacker directly at an agent's face" and "then fled through a busy intersection and raised the weed whacker again at the agent." Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. In a video released by the department on X, Barranco is seen holding the equipment, but, as noted by CNN and the Associated Press, it does not appear to have touched any of the border patrol officers. Read the original article on People
CBS News
4 days ago
- CBS News
Father of U.S. Marines in Orange County released from ICE processing center
Orange County landscaper Narcisco Barranco, the father of three U.S. Marines, was released from Adelanto's Immigration and Customs Enforcement processing center Tuesday. Immigration agents arrested the undocumented 48-year-old outside of an IHOP in Santa Ana more than three weeks ago. Barranco's family said he arrived in the United States in the 1990s and was in the process of applying for parole in place, which is a program that allows the immediate relatives of military members to apply for legal status when he was arrested. Witnesses recorded Barranco screaming in pain as four federal agents piled on top and punched him during the arrest. His son, Marine veteran Alejandro Barranco, said his father's shoulder was dislocated. Department of Homeland Security officials defended the agents' actions, adding that Barranco is "an illegal alien who tried to evade law enforcement." They said a video from the incident shows Barranco swinging a weed whacker at an agent's face and refusing to comply with commands. Alejandro said his father did not have a criminal record and instinctively raised his weed whacker after he was sprayed with a chemical agent. After three weeks in custody, Barranco was released from the Adelanto ICE facility once the family posted a bond for his release. "I was just happy that I could finally hug him and see him face-to-face and take him home," Alejandro said. "He looks sad but at the same time happy because, I mean, he's coming home finally. Outside the detention center, Alejandro explained that he feels his country has betrayed him. "I have given so much," he said. "I was ready to give the ultimate sacrifice and then this type of stuff happens, it's just not fair." Alejandro said his dad is still in pain and plans to visit a doctor. The family hopes to adjust Barranco's immigration status through parole in place. Barranco has a hearing scheduled for next month.
Yahoo
7 days ago
- Yahoo
Suspect arrested for armed robbery in Orange County
A suspect was arrested in connection with an armed robbery in Orange County. The suspect was identified as Jonathan Lopez, 22, of Santa Ana, according to the Santa Ana Police Department. On May 10, police responded to a robbery at a shopping plaza at 3321 S. Bristol Street in Santa Ana, near the South Coast Plaza mall. Surveillance video captured the female victim walking to her car at night. Moments after she arrived, the suspect drove up, stepped out and pointed his gun at her, demanding she hand over her property. He forced his way into her car and stole her wallet and a large amount of cash, police said. He fled the scene before officers arrived. Following a weeks-long investigation, detectives identified Lopez as the suspect involved. On July 9, a search warrant was served at his home where officers found the victim's belongings as well as hundreds of rounds of ammunition, two large capacity rifles and handgun magazines, and approximately $15,000 in cash. Lopez was taken into custody following the search. The case remains under investigation. Anyone with additional information can call Santa Ana police at 714-245-8049. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
